PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
28 hedge funds and large institutions have $43.9M invested in PLx Pharma Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 7 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
18% more capital invested
Capital invested by funds: $37.3M → $43.9M (+$6.59M)
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
4% more funds holding
Funds holding: 27 → 28 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCP
Tourbillon Capital Partners
New York
|
+$1.95M |
| 2 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$1.09M |
| 3 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
+$547K |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$408K |
| 5 |
FPC
Falcon Point Capital
San Francisco,
California
|
+$325K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSVM
Lone Star Value Management
Old Greenwich,
Connecticut
|
-$791K |
| 2 |
TCM
Timpani Capital Management
Milwaukee,
Wisconsin
|
-$744K |
| 3 |
Millennium Management
New York
|
-$409K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$287K |
| 5 |
OC
Oppenheimer & Co
New York
|
-$271K |
PLXP Hedge Fund Activity: Q3 2015 in Review
28 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q3 2015, worth a combined $43.9M — up 18% from $37.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PLXP positions and 7 closed out — a net gain of 1 holder — while 10 added to existing stakes and 6 trimmed.
The largest buyer was Tourbillon Capital Partners, adding an estimated $1.95M. The largest seller was Lone Star Value Management, cutting an estimated $791K.
- 28 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q3 2015, up from 27 in Q2 2015.
- Funds reported $43.9M of PLx Pharma Inc. Common Stock stock for Q3 2015, up 18% quarter-over-quarter.
- 8 funds opened new PLx Pharma Inc. Common Stock positions in Q3 2015 and 7 closed out, a net change of +1 holder.
- The largest PLx Pharma Inc. Common Stock buyer in Q3 2015 was Tourbillon Capital Partners, an estimated $1.95M added.
- The largest PLx Pharma Inc. Common Stock seller in Q3 2015 was Lone Star Value Management, an estimated $791K sold.
Based on aggregated 13F filings for Q3 2015.